Cyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds

Press/Media: Press / Media

PeriodApr 20 2015

Media coverage

31

Media coverage

  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletReuters
    CountryUnited Kingdom
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletCNN Money
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletMorningstar.com
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletSecurities Technology Monitor
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletMarket Pulse Navigator
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletFinancial Content
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletVision Monday
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletReliance Trust
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletBioSpace
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletFranklin Credit Management Corporation
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletTown Hall
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletA.M. Best
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletCEOWorld Magazine
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletIndustrial Info Financials
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletCrawford Financial Planning
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletFat Pitch Financials
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletWall Street Business Network
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletSearchBug
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletRCL Advisors
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletMarketplace
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletYahoo! Finance
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletTamar Securities
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletFinancial Content
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outlet4 Traders
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletPresentation Master
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletDigital Media Net
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletGood Day Sacramento
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletU-T San Diego
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletAsk.com
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletGlobeNewswire
    CountryUnited States
    Date4/20/15
    PersonsJing Wang
  • TitleCyclacel's Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential and Synergy With Other Anti-Cancer Compounds
    Media name/outletBizWire Express
    CountryIndia
    Date4/20/15
    PersonsJing Wang